Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials for United Therapeutics
Explore 20 clinical trials worldwide
Search
Showing 1-20 of 20 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Sponsor: United Therapeutics
Clinical Trials (20)
NCT07116681
Effects of Inhaled Treprostinil on Exercise Performance in Exercise Induced Pulmonary Hypertension
EARLY_PHASE1
Not yet recruiting
8 participants
Started: Oct 1, 2025 · Completed: Jul 1, 2027
1 condition
2 sponsors
0 locations
NCT07037836
Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia
PHASE1
Recruiting
10 participants
Started: Sep 29, 2025 · Completed: Jul 1, 2027
2 conditions
2 sponsors
1 location
NCT06878560
Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD
PHASE1/PHASE2
Recruiting
50 participants
Started: Aug 31, 2025 · Completed: Aug 31, 2075
3 conditions
1 sponsor
1 location
NCT06911632
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
NA
Recruiting
1,000 participants
Started: Jul 23, 2025 · Completed: Jul 31, 2028
2 conditions
2 sponsors
11 locations
NCT06388421
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
N/A
Recruiting
1,000 participants
Started: Jan 23, 2025 · Completed: Nov 30, 2030
3 conditions
1 sponsor
34 locations
NCT06450041
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
PHASE2
Active, not recruiting
62 participants
Started: Dec 16, 2024 · Completed: Dec 31, 2038
1 condition
4 sponsors
13 locations
NCT06477640
Home Rehabilitation Improves Cardiac Effort in Pulmonary Arterial Hypertension
NA
Recruiting
55 participants
Started: Jul 29, 2024 · Completed: Dec 31, 2026
1 condition
4 sponsors
1 location
NCT05943535
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
PHASE3
Recruiting
698 participants
Started: Oct 30, 2023 · Completed: Nov 30, 2027
2 conditions
1 sponsor
138 locations
NCT05776225
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
N/A
Recruiting
300 participants
Started: Aug 11, 2023 · Completed: Feb 28, 2026
2 conditions
1 sponsor
42 locations
NCT05421897
Rapid Administration Pilot for Infusing Dinutuximab
PHASE1
Recruiting
11 participants
Started: Nov 29, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05203510
A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension
PHASE4
Active, not recruiting
52 participants
Started: Oct 20, 2022 · Completed: Apr 30, 2028
1 condition
2 sponsors
28 locations
NCT04905693
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
PHASE3
Enrolling by invitation
1,850 participants
Started: Sep 6, 2022 · Completed: Jun 30, 2026
3 conditions
1 sponsor
187 locations
NCT04708782
Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
PHASE3
Active, not recruiting
576 participants
Started: Jun 1, 2021 · Completed: Jan 31, 2026
2 conditions
1 sponsor
99 locations
NCT04005469
Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation
PHASE1/PHASE2
Recruiting
20 participants
Started: Nov 13, 2020 · Completed: Jun 30, 2026
2 conditions
3 sponsors
1 location
NCT03814317
Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension
PHASE2
Recruiting
10 participants
Started: Jan 30, 2020 · Completed: Jul 29, 2026
3 conditions
2 sponsors
1 location
NCT03683186
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
PHASE3
Enrolling by invitation
1,000 participants
Started: Sep 23, 2019 · Completed: Dec 31, 2026
11 conditions
1 sponsor
209 locations
NCT02573896
Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
PHASE1
Active, not recruiting
13 participants
Started: Jan 14, 2019 · Completed: Sep 30, 2025
1 condition
3 sponsors
11 locations
NCT03626688
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
PHASE3
Active, not recruiting
1,000 participants
Started: Aug 30, 2018 · Completed: Dec 31, 2025
11 conditions
1 sponsor
209 locations
NCT03045029
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
N/A
Active, not recruiting
300 participants
Started: Jul 18, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
41 locations
NCT01321073
DelIVery for Pulmonary Arterial Hypertension (PAH) & Continued Support Study
NA
Active, not recruiting
64 participants
Started: Jun 30, 2011 · Completed: Dec 31, 2032
1 condition
2 sponsors
8 locations